Ameriprise’s Jade Biosciences JBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding JBIO
Ameriprise's JBIO Position: Q3 2026 in Review
Ameriprise reduced its Jade Biosciences (JBIO) stake by 24% in Q3 2026, selling an estimated $520K and leaving 81,122 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3391.
Ameriprise first reported a position in JBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.89M in Q4 2025. 162 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.
- Ameriprise held 81,122 shares of Jade Biosciences worth $1.14M as of Q3 2026.
- Ameriprise sold 25,931 Jade Biosciences shares in Q3 2026, an estimated $520K.
- Jade Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #3391 holding.
- Ameriprise first reported a position in Jade Biosciences in Q4 2025 and has held it in 3 quarters since.
- Ameriprise's Jade Biosciences position peaked at $2.89M in Q4 2025.
- 162 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.